Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
It is now only four days till my 7th wedding anniversary. Given my track record, I reckon that merits a round of applause. After you have finished the applause, I will apologise to Mr David Lenigas. If I have ever given the impression that he is a shameless ramper of worthless penny stocks, having considered his recent tweets on Wishbone Gold (WSBN) where my losses are now down to a mere £27,500, I would like to apologise. I now accept that Mr Lenigas provides quite brilliant and clear analysis of undervalued gold juniors and we should be profoundly grateful for his services. Elsewhere, I look at Avacta (AVCT), Novacyt (NCYT), Scancell (SCLP), Rurelec (RUR), and Amigo (AMGO).
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.